McKesson recalls
McKesson is named on 4 recalls in Recall Relay's records since November 2023, from FDA; the most recent was June 10, 2026.
All 4, newest first.
-
Class IIofficial
McKesson recalls Gemcitabine InjectionTemperature Abuse: Product was stored incorrectly in a controlled room temperature environment instead of a refrigerated environment.
-
Class Iofficial
McKesson recalls UDENYCATemperature Abuse. 116 cartons with specific serial numbers of Lot 2199821, were stored incorrectly in a controlled room temperature environment instead of the required refrigerated environment.
-
Class IIofficial
McKesson recalls Inflectra (infliximab-dyyb)cGMP Deviations: Product intended for quarantine was inadvertently distributed.
-
Class IIofficial
Mckesson Corporation recalls CABTREO (clindamycin phosphateCGMP Deviations: Product was stored outside labeled storage temperature requirements. Product was exposed to controlled room temperature environment instead of remaining refrigerated.
This page groups recalls by the company name the agency printed, so it can include different companies with similar names, and a recall may name a store or distributor rather than the maker. It counts the recalls in Recall Relay's records, not a company's whole history; an FDA recall that lists several products counts once. Open a recall to see its details and the agency's official notice, which is always the final word. Recall Relay isn't affiliated with any agency or with the companies named here.
Severity labels say where they come from: “official” is the agency's own class, “advisory” is based on the agency's safety warning, and “est. risk” is Recall Relay's estimate from the hazard description, not an agency classification.
Hear about the next one
Recall Relay can email you when a new recall mentions McKesson or any words you choose. Start with a free key (no card needed), then set up alerts on your account page.
Get recall alerts